...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Isotope-dilution gas chromatography-mass spectrometry coupled with injection-port butylation for the determination of 4- t -octylphenol, 4-nonylphenols and bisphenol A in human urine
【24h】

Isotope-dilution gas chromatography-mass spectrometry coupled with injection-port butylation for the determination of 4- t -octylphenol, 4-nonylphenols and bisphenol A in human urine

机译:同位素稀释气相色谱 - 质谱 - 质谱与注射口丁基化偶联,用于测定4-T-乙基苯酚,4-壬基酚和双酚A中的人尿液中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Highlights ? An isotope-dilution GC–MS with injection-port butylation was developed and validated for the determination of three EDCs. ? This highly precise and accurate method was used to determine 4- t -OP, 4-NPs and BPA in human urine. ? The precision was improved when isotope-dilution technique was employed for quantitation. ? The method can be adapted with ease by routine analysis to track and examine EDCs for human biomonitoring program. Abstract An analytical method that utilizes isotope-dilution gas chromatography-mass spectrometry (ID-GC–MS) coupled with injection-port butylation was developed. The method was validated, and confirmed to be able to determine the presence of three commonly detected endocrine-disrupting chemicals (EDCs: 4- tert -octylphenol (4- t -OP), 4-nonylphenols (4-NPs) and bisphenol A (BPA)) in human urine with high precision and accuracy. After sample preparation by solid-phase extraction, the extract was introduced into GC–MS via injection-port butylation. The butylated target analytes were identified and quantified by using ion-trap mass spectrometry operating in the selected-ion-storage mode, and employing the measurement of peak area ratios of the butylated target analytes and labeled-analogues in the samples and calibration standards. The labeled-analogues were also used to correct the variations associated with the analysis and matrix effect. The limits of quantitation (LOQs) ranged from 0.1 to 0.3ng/mL. High precisions for both intra- and inter-day analysis ranged from 1 to 6%, and excellent accuracy (mean recovery) ranged from 92 to 105% on two concentration levels. In human urine, the total concentrations of three selected EDCs varied from 1.28 to 7.14ng/mL. 4-NPs were detected within all collected samples. The developed method allows accurate analysis of trace-level of EDCs in urine, and these target EDCs could act as useful biomarkers to assess exposure in biomonitoring studies and programs.
机译:强调 ?发育并验证了具有注射口丁基化的同位素稀释GC-MS以确定三种EDC。还是这种高精度和准确的方法用于确定人类尿液中4-T -OP,4-NPS和BPA。还是当使用同位素稀释技术进行定量时,改善了精度。还是该方法可以通过常规分析轻松调整以跟踪和检查人类生物监测程序的EDC。摘要开发了一种利用同位素稀释气相色谱 - 质谱(ID-GC-MS)与注射液丁基化的分析方法进行。验证该方法,并确认能够确定三种常见的内分泌破坏化学品的存在(EDC:4-叔丁基苯酚(4-T-OP),4-壬基酚(4-NPS)和双酚A( BPA))高精度和精度的人类尿液。通过固相萃取制备在样品后,通过注射口丁基化将提取物引入GC-MS中。通过使用在所选离子储存模式下操作的离子捕获质谱法来鉴定和定量丁基化靶分析物,并采用样品和校准标准的标记 - 类似物的峰面积比测量。标记类似物还用于校正与分析和矩阵效应相关的变化。定量限制(LOQ)的限制范围为0.1至0.3ng / ml。对日内和日间分析的高精度范围为1%至6%,优异的精度(平均恢复)在两个浓度水平上的92%至105%。在人尿中,三种选择的EDC的总浓度从1.28〜7.14ng / ml变化。在所有收集的样品中检测到4nps。开发方法允许准确地分析尿液中的痕量EDC,这些目标EDC可以作为有用的生物标志物,以评估生物监测研究和计划的暴露。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号